Frederic Jean-Claude Goutte

Title: Frederic Jean-Claude Goutte: Innovator in Delayed Release Drug Formulations

Introduction

Frederic Jean-Claude Goutte is a notable inventor based in Schwoben, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of delayed release drug formulations. With a total of 2 patents to his name, Goutte's work has the potential to enhance drug delivery systems.

Latest Patents

Goutte's latest patents focus on innovative formulations that allow for the delayed release of drugs specifically to the colon. The first patent describes a formulation that includes a core containing the drug and a coating that consists of an inner layer and an outer layer. The outer layer is made from a mixture of polymeric materials that are susceptible to colonic bacteria and have a pH threshold of about 5 or above. This design aims to accelerate drug release when exposed to colonic conditions while minimizing the effects of food and alcohol on drug absorption. The second patent mirrors the first in its core concept but introduces an isolation layer, further enhancing the formulation's effectiveness.

Career Highlights

Frederic Goutte is currently associated with Tillotts Pharma AG, a company known for its focus on gastrointestinal therapies. His work at Tillotts Pharma AG has allowed him to explore and develop advanced drug delivery systems that can significantly improve patient outcomes.

Collaborations

Goutte has collaborated with several professionals in his field, including Roberto Carlos Bravo Gonzalez and Thomas Buser. These collaborations have likely contributed to the innovative nature of his patents and the overall success of his projects.

Conclusion

Frederic Jean-Claude Goutte is a prominent figure in the pharmaceutical industry, particularly in the realm of delayed release drug formulations. His innovative patents and contributions to Tillotts Pharma AG highlight his commitment to improving drug delivery systems.